Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000950170-23-031850

Options or other derivatives

  • Director acquired 6,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Freeman Roy Lester Director 2023-06-30 Grant or award · Stock Option (right to buy) +6,667 6,667 D
Loading xslF345X04/ownership.xml…